The Biomedical Catalyst: An Evaluation Report

Innovate UK and the Medical Research Council (MRC) commissioned Ipsos Mori to carry out a 2-stage review of the Biomedical Catalyst. This report provides the results of the first stage of the evaluation process.

Some of the report’s main findings include:

  • projects receiving Biomedical Catalyst funding progress faster than they would otherwise have done
  • Biomedical Catalyst funding encourages companies to switch from low risk / low return projects to those with high risk / higher return
  • stakeholders agreed that the Biomedical Catalyst aligns with Innovate UK and MRC strategies
  • applicants thought the application process was straightforward and encouraged high-quality submissions
  • marketing to the biopharma and academic communities was successful
  • the Biomedical Catalyst should seek to increase outreach to the medtech community and emerging sectors such as digital health

To read the report, please click here.

Tagged with

Published 24. March 2017 in News UK